Cargando…

Therapeutic drug monitoring of LAI antipsychotics as a predictor of clinical relapse: a one-year follow-up

INTRODUCTION: Clinical relapses in schizophrenia remain a frequent event. Long-acting injectable (LAI) antipsychotics enhance adherence, but low blood levels can sometimes be observed despite an adequate posology. Nonetheless, the evaluation of this parameter is uncommon in clinical practice. OBJECT...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Anna, G., Rotella, F., Ballerini, A., Ricca, V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2022
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9563214/ http://dx.doi.org/10.1192/j.eurpsy.2022.520

Ejemplares similares

Drug attitude inventory is relevant to LAI treatment persistence in schizophrenia: Preliminary results
por: D’Anna, G., et al.
Publicado: (2021)

An 8-year longitudinal study of long-acting injectable (LAI) antipsychotics. Prescription trends and therapeutic drug monitoring to inform precision dosing
por: Piacentino, D., et al.
Publicado: (2022)

Predictors of long-acting injectable antipsychotic treatment discontinuation in outpatients with schizophrenia: relevance of the Drug Attitude Inventory-10
por: Tatini, Lorenzo, et al.
Publicado: (2021)

Side-effect monitoring of continuing LAI antipsychotic medication in UK adult mental health services
por: Paton, Carol, et al.
Publicado: (2021)

F228. EFFECTIVENESS OF PALIPERIDONE PALMITATE VS OTHER LONG-ACTING INJECTABLE (LAI) ANTIPSYCHOTICS – AN ELECTRONIC CASE REGISTER STUDY
por: Patel, Rashmi, et al.
Publicado: (2018)

Patient and prescriber perspectives on long-acting injectable (LAI) antipsychotics and analysis of in-office discussion regarding LAI treatment for schizophrenia
por: Potkin, Steven, et al.
Publicado: (2013)

T121. RATES AND PREDICTORS OF RELAPSE FOLLOWING DISCONTINUATION OF ANTIPSYCHOTIC MEDICATION AFTER A FIRST EPISODE OF PSYCHOSIS
por: Bowtell, Meghan, et al.
Publicado: (2018)

Challenges in Treating Schizophrenia with LAIs – Analysis of Own Results
por: Todorov, A. A., et al.
Publicado: (2023)

Lais /
por: France, Marie de
Publicado: (1994)

The Effect of Switching to Long-Acting Injection (LAI) Antipsychotic Therapy on Patients with Schizophrenia
por: STRUNOIU, LIVIA MIHAELA, et al.
Publicado: (2021)

Schizophrenia treatment with a combination of two LAI antipsychotics: A case report
por: Jarosz, Marcin, et al.
Publicado: (2022)

T231. PALIPERIDONE LONG-ACTING INJECTABLE (LAI) IS ASSOCIATED WITH A LOWER INTAKE OF BENZODIAZEPINES AND A LOWER NUMBER OF ADMISSIONS COMPARED WITH OTHER LAIS IN A COHORT OF PATIENTS WITH SCHIZOPHRENIA
por: Garcia-Carmona, Juan-Antonio
Publicado: (2018)

Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania
por: Miron, Ana A., et al.
Publicado: (2022)

Aripiprazole lai two-injection start in a 16 year-old with Schizophrenia
por: Marpepa, B., et al.
Publicado: (2022)

PM499. Improvement of cognitive function before and after 2-year treatment with long-acting injection (LAI) of antipsychotics evaluated by NIRS using single word-induced hemoglobin variation as an index
por: Shoji, Yoshihisa, et al.
Publicado: (2016)

Comparison of hospitalizations in patients on first generation versus second generation long acting injectable (LAI) antipsychotics
por: Rasool, Seemab, et al.
Publicado: (2021)

Insomnia at the onset of addiction treatment may be related to earlier relapses: A one-year follow-up study
por: Álvarez, R. Palma, et al.
Publicado: (2021)

Monitoring of antipsychotic plasma levels in the assessment of poor response and nonadherence to antipsychotics in delusional disorder
por: González-Rodríguez, A., et al.
Publicado: (2021)

Estimating Leaf Area Index (LAI) in Vineyards Using the PocketLAI Smart-App
por: Orlando, Francesca, et al.
Publicado: (2016)

Materia de distintos lais /
por: Cervantes, Francisco, 1938-

Electromagnetic Fields: Lai’s Response
por: Lai, Henry
Publicado: (2004)

Improving the “real life” management of schizophrenia spectrum disorders by LAI antipsychotics: A one-year mirror-image retrospective study in community mental health services
por: Latorre, Valeria, et al.
Publicado: (2020)

13.2 CANNABIDIOL AS AN ANTIPSYCHOTIC DRUG
por: Guimaraes, Francisco, et al.
Publicado: (2018)

Non-destructive monitoring of maize LAI by fusing UAV spectral and textural features
por: Sun, Xinkai, et al.
Publicado: (2023)

Chou En-lai : la eminencia gris de China
por: Hsu, Kai-yu, 1922-
Publicado: (1974)

Can atypical antipsychotic drugs cause hepatotoxicity?
por: André, R., et al.
Publicado: (2021)

Drug-induced liver injury in association with antipsychotics
por: Zeiss, R., et al.
Publicado: (2022)

Clinical, psychopathological, and biological predictors of resumption of menses in subjects with anorexia nervosa: A 4-year follow-up study
por: Rossi, E., et al.
Publicado: (2021)

Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study
por: McKee, Kyle A., et al.
Publicado: (2021)

Psychiatric Nurses’ Knowledge and Practice Barriers to Administering Long-Acting Injectable (LAI) Antipsychotics in Taiwan: A Mixed-Methods Study
por: Lin, Yao-Yu, et al.
Publicado: (2023)

Utilization of antipsychotic therapeutic drug monitoring at a state psychiatric hospital
por: Wong, Kara R., et al.
Publicado: (2016)

Multi-Crop Green LAI Estimation with a New Simple Sentinel-2 LAI Index (SeLI)
por: Pasqualotto, Nieves, et al.
Publicado: (2019)

ValLAI_Crop, a validation dataset for coarse-resolution satellite LAI products over Chinese cropland
por: Song, Bowen, et al.
Publicado: (2021)

One year snapshot: antipsychotic use in institute of forensic psychiatry of kosovo
por: Halilaj, G., et al.
Publicado: (2023)

Clinical predictors of therapeutic response to antipsychotics in schizophrenia
por: Carbon, Maren, et al.
Publicado: (2014)

Thrombotic complications of treatment with antipsychotic drugs : risk factors
por: Abid, W., et al.
Publicado: (2023)

The Use of Long-Acting Injectable Antipsychotics (LAI) in the Serious Mental Illness (SMI) Patients Enrolled in an Assertive Community Treatment (ACT) Program
por: Yee, Maria Ruiza, et al.
Publicado: (2021)

F143. PREDICTORS OF RELAPSE: PATIENT, DISEASE, COGNITIVE, AND FUNCTIONAL CHARACTERISTICS WITH COMT GENE VAL158MET POLYMORPHISM IN A 2-YEAR FOLLOW-UP
por: Khan, Anzalee, et al.
Publicado: (2018)

The effect of Working Alliance on drug attitude in patients with Major Depressive Disorder
por: Santarelli, G., et al.
Publicado: (2022)

1562. Renal Outcomes after Switch from Oral Antiretroviral therapy (ART) to Long-acting injectable Cabotegravir/Rilpivirine (LAI CAB)
por: Ayala, Alvaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_umnuvq7m4iie2fcvme5c95il1c